Jürgen Venitz

3.7k total citations
87 papers, 2.9k citations indexed

About

Jürgen Venitz is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jürgen Venitz has authored 87 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Molecular Biology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jürgen Venitz's work include Hemoglobin structure and function (15 papers), Hemoglobinopathies and Related Disorders (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Jürgen Venitz is often cited by papers focused on Hemoglobin structure and function (15 papers), Hemoglobinopathies and Related Disorders (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Jürgen Venitz collaborates with scholars based in United States, Germany and Egypt. Jürgen Venitz's co-authors include William D. Figg, Alex Sparreboom, William D. Figg, Nehal J. Lakhani, Milin Acharya, William L. Dahut, Lokesh Jain, Mohamadi Sarkar, Christopher Dufton and Seth M. Steinberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemistry.

In The Last Decade

Jürgen Venitz

86 papers receiving 2.8k citations

Peers

Countries citing papers authored by Jürgen Venitz

Since Specialization

Citations

This map shows the geographic impact of Jürgen Venitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Venitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Venitz more than expected).

Fields of papers citing papers by Jürgen Venitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Venitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Venitz. The network helps show where Jürgen Venitz may publish in the future.

Co-authorship network of co-authors of Jürgen Venitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Venitz. A scholar is included among the top collaborators of Jürgen Venitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Venitz. Jürgen Venitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions 2020 ·Scientific Reports ·Osheiza Abdulmalik, Piyusha P. Pagare, Boshi Huang, Guoyan Xu, Mohini S. Ghatge, (unknown), Qiukan Chen, (unknown), Faik N. Musayev, Abdelsattar M. Omar, Jürgen Venitz, Yan Zhang, Martin K. Safo	18
2	In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing 2015 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Renishkumar Delvadia, (unknown), P. Worth Longest, Jürgen Venitz, Peter R. Byron	46
3	Cumulative Organic Anion Transporter-Mediated Drug-Drug Interaction Potential of Multiple Components in Salvia Miltiorrhiza (Danshen) Preparations 2014 ·Pharmaceutical Research ·Li Wang, Jürgen Venitz, Douglas H. Sweet	9
4	Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters 2012 ·Expert Opinion on Drug Metabolism & Toxicology ·Aditi Mulgaonkar, Jürgen Venitz, Douglas H. Sweet	25
5	Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin 2011 ·Acta Crystallographica Section D Biological Crystallography ·Osheiza Abdulmalik, Mohini S. Ghatge, Faik N. Musayev, (unknown), Qiukan Chen, Jisheng Yang, (unknown), Richmond Danso‐Danquah, (unknown), Toshio Asakura, Donald J. Abraham, Jürgen Venitz, Martin K. Safo	42
6	Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs 2011 ·Toxicology ·Michael S. Werley, P. McDonald, Patrick D. Lilly, (unknown), (unknown), Peter R. Byron, Jürgen Venitz	60
7	Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib 2010 ·Journal of Experimental & Clinical Cancer Research ·Lokesh Jain, Tristan M. Sissung, Romano Danesi, Elise C. Kohn, William L. Dahut, Shivaani Kummar, David Venzon, David J. Liewehr, Bevin C. English, Caitlin E. Baum, Robert Yarchoan, Giuseppe Giaccone, Jürgen Venitz, Douglas K. Price, William D. Figg	82
8	The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors 2009 ·Molecular Cancer Therapeutics ·Lokesh Jain, Craig Vargo, Romano Danesi, Tristan M. Sissung, Douglas K. Price, David Venzon, Jürgen Venitz, William D. Figg	146
9	Final analysis of a phase II trial using sorafenib for metastatic castration‐resistant prostate cancer 2009 ·British Journal of Urology ·Jeanny B. Aragon‐Ching, Lokesh Jain, James L. Gulley, Philip M. Arlen, James R. Wright, Seth M. Steinberg, David E. Draper, Jürgen Venitz, Elizabeth C. Jones, Clara C. Chen, William D. Figg, William L. Dahut	91
10	The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers 2009 ·British Journal of Clinical Pharmacology ·Gennyne Walker, Arun Mandagere, Christopher Dufton, Jürgen Venitz	31
11	A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer 2008 ·Clinical Cancer Research ·William L. Dahut, Charity D. Scripture, Edwin M. Posadas, Lokesh Jain, James L. Gulley, Philip M. Arlen, James R. Wright, Yunkai Yu, Liang Cao, Seth M. Steinberg, Jeanny B. Aragon‐Ching, Jürgen Venitz, Elizabeth C. Jones, Clara C. Chen, William D. Figg	142
12	Development of a rapid and sensitive LC–MS/MS assay for the determination of sorafenib in human plasma 2007 ·Journal of Pharmaceutical and Biomedical Analysis ·Lokesh Jain, Erin R. Gardner, Jürgen Venitz, William L. Dahut, William D. Figg	57
13	Determination of MS-275, a novel histone deacetylase inhibitor, in human plasma by liquid chromatography–electrospray mass spectrometry 2004 ·Journal of Chromatography B ·Kyunghwa Hwang, Milin Acharya, Edward A. Sausville, Suoping Zhai, (unknown), Jürgen Venitz, William D. Figg, Alex Sparreboom	12
14	Factors Involved in the Pharmacokinetics of COL‐3, a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer: Clinical and Experimental Studies 2003 ·The Journal of Clinical Pharmacology ·Michelle A. Rudek, Jürgen Venitz, Yukio Ando, Eddie Reed, James M. Pluda, William D. Figg	12
15	Solute disposition in the rat lung in vivo and in vitro: Determining regional absorption kinetics in the presence of mucociliary escalator 2002 ·Journal of Pharmaceutical Sciences ·Masahiro Sakagami, Peter R. Byron, Jürgen Venitz, František Rypáček	22
16	Antiangiogenesis Therapeutic Strategies in Prostate Cancer 2002 ·Cancer and Metastasis Reviews ·Gordon R. Macpherson, Sylvia S. W. Ng, Nehal J. Lakhani, Douglas K. Price, Jürgen Venitz, William D. Figg	6
17	Evaluation of Truncated Areas in the Assessment of Bioequivalence of Immediate Release Formulations of Drugs with Long Half-Lives and of Cmax with Different Dissolution Rates 1999 ·Pharmaceutical Research ·Pradeep Sathe, Jürgen Venitz, Lawrence J. Lesko	19
18	Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin 1997 ·Journal of Antimicrobial Chemotherapy ·John Vincent, Jürgen Venitz, Rongyue Teng, (unknown), Susan Willavize, R J Polzer, H. Friedman	59
19	Comparison of Methods for the Assessment of Central Nervous System Stimulant Response after Dextroamphetamine Administration to Healthy Male Volunteers 1996 ·The Journal of Clinical Pharmacology ·Patricia W. Slattum, Jürgen Venitz, William H. Barr	20
20	Determination of unbound L‐tryptophan in human plasma using high‐performance liquid chromatography with fluorescence detection 1995 ·Biomedical Chromatography ·(unknown), Clark March, Jürgen Venitz	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact